The federal government has placed its first order for a stockpile of cefiderocol, an antibiotic held in reserve for infections that few other drugs can treat.
The Biomedical Advanced Research and Development Authority exercised a $36.9 million procurement option through Project BioShield, its program for buying medical countermeasures. The purchase covers an antibiotic aimed at two overlapping threats: gram-negative bacterial infections that have defeated other options, and pathogens that could be used deliberately.
